Cargando…

The FDA “Black Box” Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits?

The decision made in the year 2004 by the U.S. Food and Drug Administration (FDA) to require a boxed warning on antidepressants regarding the risk of suicidality in young adults still represents a matter of controversy. The FDA warning was grounded on industry-sponsored trials carried one decade ago...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fornaro, Michele, Anastasia, Annalisa, Valchera, Alessandro, Carano, Alessandro, Orsolini, Laura, Vellante, Federica, Rapini, Gabriella, Olivieri, Luigi, Di Natale, Serena, Perna, Giampaolo, Martinotti, Giovanni, Di Giannantonio, Massimo, De Berardis, Domenico
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510161/ https://www.ncbi.nlm.nih.gov/pubmed/31130881 http://dx.doi.org/10.3389/fpsyt.2019.00294

Ejemplares similares

Protein-C Reactive as Biomarker Predictor of Schizophrenia Phases of Illness? A Systematic Review
por: Orsolini, Laura, et al.
Publicado: (2018)

Alexithymia and Suicide Risk in Psychiatric Disorders: A Mini-Review
por: De Berardis, Domenico, et al.
Publicado: (2017)

Religious Coping, Hopelessness, and Suicide Ideation in Subjects with First-Episode Major Depression: An Exploratory Study in the Real World Clinical Practice
por: De Berardis, Domenico, et al.
Publicado: (2020)

Adjunctive vortioxetine for SSRI-resistant major depressive disorder: a “real-world” chart review study
por: De Berardis, Domenico, et al.
Publicado: (2020)

Alexithymia, Suicide Ideation and Homocysteine Levels in Drug Naïve Patients with Major Depression: A Study in the “Real World” Clinical Practice
por: De Berardis, Domenico, et al.
Publicado: (2019)

The Role of Inhaled Loxapine in the Treatment of Acute Agitation in Patients with Psychiatric Disorders: A Clinical Review
por: de Berardis, Domenico, et al.
Publicado: (2017)

Celecoxib Adjunctive Treatment to Antipsychotics in Schizophrenia: A Review of Randomized Clinical Add-On Trials
por: Marini, Stefano, et al.
Publicado: (2016)

Eradicating Suicide at Its Roots: Preclinical Bases and Clinical Evidence of the Efficacy of Ketamine in the Treatment of Suicidal Behaviors
por: De Berardis, Domenico, et al.
Publicado: (2018)

Trazodone Add-on in COVID-19-related Selective Serotonin Reuptake Inhibitor-resistant Post-traumatic Stress Disorder in Healthcare Workers: Two Case Reports
por: Berardis, Domenico De, et al.
Publicado: (2021)

Clozapine-related Sudden Pericarditis in a Patient Taking Long Acting Aripiprazole and Valproate: A Case Report
por: De Berardis, Domenico, et al.
Publicado: (2018)

Agomelatine beyond Borders: Current Evidences of Its Efficacy in Disorders Other than Major Depression
por: De Berardis, Domenico, et al.
Publicado: (2015)

Successful Ziprasidone Monotherapy in a Case of Delusional Parasitosis: A One-Year Followup
por: De Berardis, Domenico, et al.
Publicado: (2013)

The Relationships between Cholesterol and Suicide: An Update
por: De Berardis, Domenico, et al.
Publicado: (2012)

Suicide in Healthcare Workers: Determinants, Challenges, and the Impact of COVID-19
por: Awan, Sana, et al.
Publicado: (2022)

S-Adenosyl-L-Methionine Augmentation in Patients with Stage II Treatment-Resistant Major Depressive Disorder: An Open Label, Fixed Dose, Single-Blind Study
por: De Berardis, Domenico, et al.
Publicado: (2013)

The Melatonergic System in Mood and Anxiety Disorders and the Role of Agomelatine: Implications for Clinical Practice
por: De Berardis, Domenico, et al.
Publicado: (2013)

Emotional Dysregulation in Adolescents: Implications for the Development of Severe Psychiatric Disorders, Substance Abuse, and Suicidal Ideation and Behaviors
por: De Berardis, Domenico, et al.
Publicado: (2020)

Understanding the Complex of Suicide in Depression: from Research to Clinics
por: Orsolini, Laura, et al.
Publicado: (2020)

Earthquakes, economic crisis and, now, COVID-19: the cry of yell of Central Italy.
por: De Berardis, Domenico, et al.
Publicado: (2020)

Overcoming the Use of Mechanical Restraints in Psychiatry: A New Challenge in the Everyday Clinical Practice at the Time of COVID-19
por: De Berardis, Domenico, et al.
Publicado: (2020)

Cariprazine Add-on in Inadequate Clozapine Response: A Report on Two Cases
por: Berardis, Domenico De, et al.
Publicado: (2021)

Treating the Synapse in Major Psychiatric Disorders: The Role of Postsynaptic Density Network in Dopamine-Glutamate Interplay and Psychopharmacologic Drugs Molecular Actions
por: Tomasetti, Carmine, et al.
Publicado: (2017)

Suicide during Perinatal Period: Epidemiology, Risk Factors, and Clinical Correlates
por: Orsolini, Laura, et al.
Publicado: (2016)

Assessing provider and racial/ethnic variation in response to the FDA antidepressant box warning
por: Cook, Benjamin L., et al.
Publicado: (2019)

Prevalence and clinical features associated with bipolar disorder polypharmacy: a systematic review
por: Fornaro, Michele, et al.
Publicado: (2016)

Gut Microbiota and Bipolar Disorder: An Overview on a Novel Biomarker for Diagnosis and Treatment
por: Lucidi, Lorenza, et al.
Publicado: (2021)

Atypical Antipsychotics in the Treatment of Acute Bipolar Depression with Mixed Features: A Systematic Review and Exploratory Meta-Analysis of Placebo-Controlled Clinical Trials
por: Fornaro, Michele, et al.
Publicado: (2016)

Commentary: What Happens to Subjects with Impaired Emotion Recognition Skills, and What To Do?
por: De Berardis, Domenico, et al.
Publicado: (2022)

A Possible Next Covid-19 Pandemic: The Violence Against Women and Its Psychiatric Consequences
por: De Berardis, Domenico, et al.
Publicado: (2021)

Obsessive-Compulsive Aspects and Pathological Gambling in an Italian Sample
por: Petruccelli, Filippo, et al.
Publicado: (2014)

Challenging the FDA Black Box Warning for High Aspirin Dose With Ticagrelor in Patients With Diabetes
por: DiNicolantonio, James J., et al.
Publicado: (2013)

Duty to Warn: Antidepressant Black Box Suicidality Warning Is Empirically Justified
por: Spielmans, Glen I., et al.
Publicado: (2020)

Risk for Postmarket Black Box Warnings in FDA-Approved Monoclonal Antibodies
por: Hagan, John B., et al.
Publicado: (2021)

Public Perceptions of Breast Implant Complications and the FDA Boxed Warning on Implants
por: Hyland, Colby J., et al.
Publicado: (2022)

Lisdexamfetamine in the treatment of moderate-to-severe binge eating disorder in adults: systematic review and exploratory meta-analysis of publicly available placebo-controlled, randomized clinical trials
por: Fornaro, Michele, et al.
Publicado: (2016)

Commentary: Duty to Warn: Antidepressant Black Box Suicidality Warning is Empirically Justified
por: Goodman, Wayne K., et al.
Publicado: (2020)

Editorial: Understanding the Complex Phenomenon of Suicide: From Research to Clinical Practice
por: De Berardis, Domenico, et al.
Publicado: (2018)

Relationship between Health-Anxiety and Cyberchondria: Role of Metacognitive Beliefs
por: Nadeem, Faiza, et al.
Publicado: (2022)

1863. Antibiotic Prescribing Before and After an FDA Boxed Warning on Fluoroquinolones in 2016
por: Willis, Zachary, et al.
Publicado: (2018)

Agomelatine Increases BDNF Serum Levels in Depressed Patients in Correlation with the Improvement of Depressive Symptoms
por: Martinotti, Giovanni, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_iphb0sse06mbg5dhkl3hhvh791